American Cannabis Company, Inc. and KORcannabis Aim to Advance the Cannabis Industry with Newly Formed Strategic Alliance

American Cannabis Company partners with KORcannabis

American Cannabis Company, Inc. (ACC), a business-to-business cannabis consulting solutions provider and licensed owner-operator, and KORcannabis, one of the nation’s most advanced multi-state seed-to-sale operators, announced today that they have formed a high-impact strategic alliance to revolutionize the cannabis industry with innovative technology, clinical research, and novel agricultural practices.

The mutually beneficial relationship leverages the two entities’ highly specialized skillset working in tandem for the betterment of the burgeoning industry. ACC brings years of success providing comprehensive consulting services to complement KORcannabis‘ commitment to product quality and sustainability as well as its innovative approach to patient care. The combined strengths of both firms will help drive new industry standards to create an optimal end-user experience.

Our strategic alliance with ACC stems from trust due to their vast experience in the field of cannabis. Ellis Smith and his team have years of industry knowledge throughout the US, which has culminated in their development of a state-of-the-art platform ranging from business development, licensing strategies, cultivation, extraction to facility design. I am excited to execute the plan developed by Ellis and work hand in hand with his team,” said Scotty Branch, co-owner of KORcannabis.

The KORcannabis and ACC strategic alliance establishes a new industry standard known as Farmaganix. This cultivation methodology combines Clean Green Certified® SoHum Living Soils® with proprietary cultivation practices to create the safest and most effective plant therapies for cannabis users.

Currently, KORcannabis is working with ACC on a new state-of-the-art super facility in Scottsdale, Arizona. In unprecedented fashion, this highly advanced, laboratory-grade indoor cultivation facility contains over 4000 lights, a full pharmaceutical-grade lab, and in-house quality control and analytical testing capabilities. All equipment, infrastructure, and processes are being developed to GMP / EUGMP / ISO standards and qualifications.

Simultaneous to the Arizona buildout, KORcannabis is working with ACC to launch a facility in Mississippi. They plan to reach a third state in 2022 and three more in 2023. Also, KORcannabis is growing its clinical research division, which focuses on the development of targeted cannabis therapies and drug delivery devices.

“I’m thrilled we can align with KORcannabis to assist in rapidly nationalizing the company’s footprint to key geographical areas and high-growth markets. They have built a reputation of excellence and are on the cutting edge of the emerging cannabis market,” said Ellis Smith, CEO of American Cannabis Company.

About American Cannabis Company, Inc.

American Cannabis Company, Inc. offers clean green solutions to existing and aspiring participants in the cannabis and hemp industries. They utilize their industry expertise to provide business planning and market assessment services, assist state licensing procurement, and create business infrastructure operational best practices. ACC currently owns and operates Naturaleaf in Colorado Springs, Colorado. This medically licensed entity consists of three retail dispensaries, one commercial cultivation facility, and one non-volatile extraction operation. American Cannabis Company has also developed SoHum Living Soils®, a winner of the High Times S.T.A.S.H. Award for “Best Potting Mix.” SoHum Living Soils® products are also OMRI Listed® and Clean Green Certified®.

For more information about American Cannabis Company, please visit:

www.theacclife.com

www.americancannabisconsulting.com
www.sohumsoils.com

 

Video Links:

https://americancannabisconsulting.com/resources/video/ (ACC Site)

https://www.youtube.com/watch?v=XoIcopO2yE8&t (SoHum Living Soils®)

 

ACC Contact:
[email protected]

303-974-4770

For more information about KORcannabis, please visit:

www.korcannabis.co

Forward-Looking Statements

This news release contains “forward-looking statements,” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”. These or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

Cannabis Remains an Illegal Schedule 1 Drug Under Federal Law

Thirty-five states, including Colorado, the District of Columbia and four U.S. Territories currently have laws broadly legalizing cannabis in some form for either medicinal and/or recreational use governed by state specific laws and regulations. Although legalized in some states, cannabis is a “Schedule 1” drug under the Controlled Substances Act (21 U.S.C. § 811) (“CSA”) and is illegal under federal law. Cannabis and its derivatives are viewed as being highly addictive and having no medical value. The United States Drug Enforcement Agency enforces the Controlled Substances Act, and persons violating it are subject to federal criminal prosecution.

As a result of the November 2020 federal elections, and the election of Joseph R. Biden as president, it is expected that the federal government will move to amend parts of the CSA and de-schedule cannabis as a Schedule 1 drug.

In late January 2021, Senate Majority Leader Chuck Schumer said lawmakers are in the process of merging various cannabis bills, including his own legalization legislation. He is working to enact reform in this Congressional session. This would include the Marijuana Freedom and Opportunity Act, which would federally de-schedule cannabis, reinvest tax revenue into communities most affected by the drug war, and fund efforts to expunge prior cannabis records. It is likely that the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act would be incorporated.

Other federal legislation under review for possible submission includes the SAFE Banking Act (or Secure and Fair Enforcement Act), a bill that would allow cannabis companies to access the federally-insured banking system and capital markets without the risk of federal enforcement action, and the Strengthening the Tenth Amendment Through Entrusting States Act (or STATES Act), a bill that seeks protections for businesses and individuals in states that have legalized and comply with state laws).

Notably with respect to our business, on November 1, 2019, Colorado Bill HB-19-1090, was passed and made effective. This law allows publicly traded corporations to apply for and qualify for the ownership of Colorado cannabis licenses. Other states that have legalized cannabis for recreational and/or medicinal use restrict public companies from owning interests in state cannabis licenses altogether, or have enacted regulations which make it difficult for corporations to comply with application requirements, including all shareholders submitting to and passing background checks.

On September 18, 2020, Colorado’s Marijuana Enforcement Division (MED), approved the Company’s application for suitability, establishing the Company as one of the few publicly traded companies authorized to acquire and operate various cannabis licenses throughout Colorado, in both the recreational and medical markets.

American Cannabis Company Partners with Bubba Kush Cannabis Brand

American Cannabis Company, Inc. (ACC), a business-to-business cannabis consulting solutions provider and licensed owner operator, is pleased to announce a partnership with the Bubba Kush cannabis brand.

As part of this partnership, ACC will provide extensive cultivation and consulting services to Bubba Kush, and work closely with them to produce  a line of Clean Green Certified® cannabis. In addition, ACC will produce, package, sell and distribute the Bubba Kush brand across Colorado.

“I am truly excited to work with the Bubba Kush brands and support such a long-standing cannabis strain that has been a staple in gardens for over 25 years. Our goal is to build on our relationship with the Bubba Kush brand and expand into new markets with them,” said Ellis Smith, co-founder and CEO of American Cannabis Company.

This partnership also gives ACC the opportunity to offer top-tier, organically based products at their Naturaleaf retail dispensaries, located in the Colorado Springs area.

“We see this as a partnership that will allow us to not only have a top-notch grow partner in the medical market of Colorado, but also to pursue other collaborations as a team throughout the legal cannabis industry,” said Reggie Harris, CEO and co-founder of BK Brand Wellness, LLC. “We are very careful with whom we will align our brand and grow alongside. Ellis and his team really embrace the journey of bringing legacy genetics to the current marketplace while looking for new innovations in this fast-changing industry. We believe this provides a great complement to the Bubba Kush core values and objectives.”

Ultimately, this partnership is a true win for the conscious cannabis consumer in Colorado. Each year, there is a growing number of individuals who prefer to consume high quality, clean green cannabis products which are both better for the environment and provide a more enjoyable smoking experience.

About American Cannabis Company, Inc.

American Cannabis Company, Inc. offers clean green solutions to existing and aspiring participants in the cannabis and hemp industries. They utilize their industry expertise to provide business planning and market assessment services, assist state licensing procurement, and create business infrastructure operational best practices. This medically licensed entity consists of three retail dispensaries, one commercial cultivation facility, and one non-volatile extraction operation. American Cannabis Company has also developed SoHum Living Soils®, a winner of the High Times S.T.A.S.H. Award for “Best Potting Mix.” SoHum Living Soils® products are also OMRI Listed® and Clean Green Certified®.

For more information about American Cannabis Company, please visit:

www.theacclife.com
www.americancannabisconsulting.com
www.americancannabiscompanyinc.com
www.sohumsoils.com
www.thenaturaleaf.com

Video Links:

https://americancannabisconsulting.com/resources/video/ (ACC Site)
https://www.youtube.com/watch?v=XoIcopO2yE8&t (SoHum Living Soils®)

ACC Contact:
[email protected]

Phone: (303) 974-4770

Forward-Looking Statements

This news release contains “forward-looking statements,” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”. These or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

Cannabis Remains an Illegal Schedule 1 Drug Under Federal Law

Thirty-five states, including Colorado, the District of Columbia and four U.S. Territories currently have laws broadly legalizing cannabis in some form for either medicinal and/or recreational use governed by state specific laws and regulations. Although legalized in some states, cannabis is a “Schedule 1” drug under the Controlled Substances Act (21 U.S.C. § 811) (“CSA”) and is illegal under federal law. Cannabis and its derivatives are viewed as being highly addictive and having no medical value. The United States Drug Enforcement Agency enforces the Controlled Substances Act, and persons violating it are subject to federal criminal prosecution.

As a result of the November 2020 federal elections, and the election of Joseph R. Biden as president, it is expected that the federal government will move to amend parts of the CSA and de-schedule cannabis as a Schedule 1 drug.

In late January, 2021, Senate Majority Leader Chuck Schumer said lawmakers are in the process of merging various cannabis bills, including his own legalization legislation. He is working to enact reform in this Congressional session. This would include the Marijuana Freedom and Opportunity Act, that would federally de-schedule cannabis, reinvest tax revenue into communities most affected by the drug war, and fund efforts to expunge prior cannabis records. It is likely that the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act would be incorporated.

Other federal legislation under review for possible submission includes the SAFE Banking Act (or Secure and Fair Enforcement Act), a bill that would allow cannabis companies to access the federally-insured banking system and capital markets without the risk of federal enforcement action, and the Strengthening the Tenth Amendment Through Entrusting States Act (or STATES Act), a bill that seeks protections for businesses and individuals in states that have legalized and comply with state laws).

Notably with respect to our business, on November 1, 2019, Colorado Bill HB-19-1090, was passed and made effective. This law allows publicly traded corporations to apply for and qualify for the ownership of Colorado cannabis licenses. Other states that have legalized cannabis for recreational and/or medicinal use restrict public companies from owning interests in state cannabis licenses altogether, or have enacted regulations which make it difficult for corporations to comply with application requirements, including all shareholders submitting to and passing background checks.

On September 18, 2020, Colorado’s Marijuana Enforcement Division (MED), approved the Company’s application for suitability, establishing the Company as one of the few publicly traded companies authorized to acquire and operate various cannabis licenses throughout Colorado, in both the recreational and medical markets.

American Cannabis Company, Inc. Provides Overall Update on Company Progress and Plans for 2022

American Cannabis Company, Inc., a business-to-business cannabis consulting solutions provider and licensed owner operator, is pleased to provide an overall update on Company progress and its plans for 2022.

The Company looks forward to a busy year in 2022 across all brands within its portfolio. Since its inception in 2013, much of ACC’s success was derived upon being a provider of end-to-end consulting services. The Company has spent considerable time aligning itself with strategies for long-term scalability and sustainability. The acquisition of Naturaleaf in April of last year gave ACC its first pivot point into a new core focus of overall business, providing the catalyst needed to connect its overall brand identity with clean green and organically based cannabis cultivation. Moving forward, the Company plans to focus on four primary areas of business that will further promote its clean green cannabis cultivation mission: operational management consulting, SoHum Living Soils®, Naturaleaf cultivation and dispensaries, and brand expansion by means of strategic mergers and acquisitions.

Ellis Smith, Co-Founder and the new CEO of American Cannabis Company, Inc. said: “This is going to be a very exciting year for the Company. We are now in a position to deploy our ‘cage-free cannabis’ products and services across all brands under the parent company umbrella. With this ability to now showcase our passion and expertise for a consistent high quality cannabis experience, ACC will continue to implement means to further validate our mission. We will continue to show the market how our products stand apart from other commercially manufactured products.”

In late 2021, the Company received an official certification from the Organic Materials Review Institute (OMRI) for its product, SoHum Living Soils®. This product is a fully amended, pH-buffered growing medium that will continue to disrupt the agricultural markets as a ‘Just Add Water’ super soil, acting to eliminate the human error element from cannabis and non-cannabis crop cultivation. SoHum Living Soils® was created to combat complex cannabis cultivation strategies as it is a complete living soil that optimizes a plant’s genetic potential. Designed to be ready to use, SoHum Living Soils® is a complete and diverse solution for both indoor and outdoor cultivation, combining the best of modern science and agriculture with traditional expertise and farming practices. With this recent approval from OMRI, SoHum Living Soils® is officially OMRI Listed® and appears on the OMRI Products Lists©.

In addition to this prominent certification, The Company recently secured Clean Green Certification for SoHum Living Soils® as well as for all products grown and manufactured under the Naturaleaf cultivation facility. To become Clean Green Certified® in both areas means that the flower product and biproduct, the facility, the cultivating processes, and input materials uphold strict standards that are consistently maintained under organically based regulations. Retail bags of SoHum Living Soils® are now carried in over one hundred and fifty (150+) retail stores and is a strategic growing component for many commercial cannabis cultivators.  SoHum’s OMRI Listed® and Clean Green dual certification gives cultivators confidence in using this living soil solution as part of their organic growing process.

“We are at a very pivotal point in our Company. After having spent many years developing and refining our brand strategy, all brands under the American Cannabis Company name are now in alignment with the core mission to elevate the consumer experience by commiting to wellness, quality products and organically based practices” said Tyler Schloesser, Chief Operating Officer of American Cannabis Company, Inc. Mr. Schloesser continued: “We have the ability to offer Clean Green Certified® products that are grown using OMRI Listed® and Clean Green Certified® inputs, and this certainly differentiates us in the market.”

Through its plant-touching operation, Naturaleaf, the Company is actively selling Clean Green Certified® flower to medical patients through its three (3) retail channels within the city of Colorado Springs. The mission of the Company continues as it has worked with the Naturaleaf team to now offer Clean Green Certified® cannabis clones to the market along with an entire line of wholesale products including organically based flower, trim, and clone stock. Additionally, ACC has recently partnered with the official Bubba Kush brand to be the provider of clean green quality cannabis to the Colorado market. This opportunity gives the Company the ability to maximize the genetic potential of each licensed strain and allows for ACC and Naturaleaf to offer top-tier, organically based products to the conscious cannabis consumer.

On the consulting side of the Company, ACC is implementing its core mission and values across all projects related to existing clients. Currently, the Company is working on several large-scale cultivation operational deployment and management activities for clients in both Michigan and Arizona. When completed, these operations will be managed by ACC and set to produce quality cannabis that is cultivated using practices that are consistent, replicable, and clean.

Ellis Smith commented: “We are excited to be able to adapt and apply our processes, methodologies, and technological resources to our current client projects as well as all future clients and partners that seek to up-level the way in which cannabis is produced in their respective region(s) of the world. Our brand identity stands upon quality, and with that being said, I think it’s important to convey this steadfast approach that our team holds to redefine society’s relationship with cannabis through responsible stewardship. We are approaching 2022 with a clear focus, and we will continue to expand our footprint and scale all of our brands with a push toward clean green, organically based practices.”

American Cannabis Company, Inc. Receives Official Organic Materials Review Institute (OMRI) Certification for Its SoHum Living Soils® Product Line

American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC” or “Company”), a full-service business-to-business cannabis and hemp consulting solutions provider and licensed owner operator, is pleased to announce that its proprietary potting mix, SoHum Living Soils®, was recently awarded an official certification from the Organic Materials Review Institute (OMRI).

OMRI’s mission is to provide the agricultural industry with peace of mind in knowing that quality materials are consistent and organic as a standard. This organization provided an independent review of SoHum Living Soils®, looking at each individual input that is intended for use in certified organic cultivation and production.

“This is a major achievement for the SoHum Living Soils® product line, “said Terry Buffalo, Chief Executive Officer for American Cannabis Company, Inc. “OMRI certification solidifies our soil product as a top-tier medium for cannabis cultivation. Being OMRI Listed® gives organic farmers a means to verify the credibility of our products, providing assurance that the highest quality ingredients are consistently utilized in soil manufacturing,” continued Buffalo.

SoHum Living Soils® is a fully amended, pH-buffered growing medium that will continue to disrupt the agricultural markets as a ‘Just Add Water’ super soil, acting to eliminate the human error element from cannabis and non-cannabis crop cultivation. Awarded the High Times S.T.A.S.H Award for “Best Potting Mix”, SoHum Living Soils® was created to combat complex cannabis cultivation strategies as it is a complete living soil that optimizes a plant’s genetic potential. Designed to be ready to use, SoHum Living Soils® is a complete and diverse solution for both indoor and outdoor cultivation, combining the best of modern science and agriculture with traditional expertise and farming practices. With this recent approval from OMRI, SoHum Living Soils® is now officially OMRI Listed® and appears on the OMRI Products Lists©.

Ellis Smith, Co-founder and President of American Cannabis Company, Inc., commented: “We are very excited as a team to now have an OMRI certified product to offer cannabis cultivators across the country. It has taken years to develop the blend to where it is today, and this certification puts SoHum Living Soils® on the map as a solution to produce high quality, organic cannabis on both small and commercial scales.”

Those looking to purchase SoHum Living Soils® can do so by contacting an official distributor or visiting the SoHum Living Soils® website at www.sohumsoils.com (for store locator, see https://sohumsoils.com/shop-living-soil/#storelocator). The SoHum Living Soils® potting mix is also available for purchase on the Walmart, The Home Depot and Amazon online store platforms.

To see the OMRI Listed® certificate for SoHum Living Soils®, click here.

American Cannabis Company, Inc. Provides Overall Company Update on Year-To-Date Progress

DENVER, CO / NEWMEDIAWIRE / September 1, 2021 American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC” or “Company”), a full-service business-to-business cannabis and hemp consulting solutions provider and licensed owner operator, is pleased to provide an overall update on the Company. The following information describes the Company’s challenges, current work efforts and future pursuits as it positions itself as a reputable and established brand within the regulated markets.

Summary of 2021 YTD Company Highlights

  • Successfully acquired Naturaleaf, a long-standing vertically integrated licensed medical cannabis operation, in Colorado Springs, Colorado.
  • Continued ongoing exploration of acquisition opportunities in all regulated markets.
  • Developed working relationship with a client group in Michigan to deploy, manage, and monitor large-scale commercial cultivation operations.
  • Developed a working relationship with a separate client group in Michigan to develop, deploy, and manage multiple licensed retail franchise operations throughout the state
  • Contracted by client in Connecticut to finalize business plan and financial pro forma modeling for a recreational dispensary.
  • Contracted with a client in New Mexico for pre-licensing, design, and state application technical writing services with the goal of building out a vertically integrated recreational cannabis business.
  • Completed a business plan and financial pro forma model for a client in Oklahoma that has finalized a lease. ACC will be the management company behind this operation.
  • Completed a business plan and financial pro forma model for a client in Oklahoma looking to build a medical cultivation operation. ACC will also be the management company behind this operation.
  • Provided multiple a la carte consulting services for a client in Florida looking to launch an indoor boutique hemp production facility. The Company has been further retained to provide equipment sourcing, SoHum Living Soils®, operational deployment, and 6-month deployment and management services.
  • Completed business a plan and pro forma for client cannabis business in New Jersey looking to open a social equity-driven recreational dispensary.
  • Engaged in research and development of new products under the SoHum Living Soils® brand line.
  • Officially launched new air circulation technology, Bottoms uP™ : The Science of Air Flow.
  • Signed an exclusive agreement to manufacture and distribute Her Highness NYC products to Colorado medical and recreational markets.

Consulting Division & The Lasting Impacts of COVID-19

The Company has continued to experience various changes in the volume of new business due to the impact of the COVID-19 global pandemic. With spread of the delta variant of COVID-19 gaining becoming more prevalent, the economic climate continues to shift. In addition, there has been a slow rollout of states with new Medical or Adult-Use cannabis programs.

“It has been a challenging year for the consulting side of the business” said Terry Buffalo, CEO of American Cannabis Company, Inc. “Our primary revenue driver for consulting is typically based on new cannabis programs. However, with states not moving forward with application processes at this time it has slowed down the need for many client groups to pursue any pre-licensing services or deliverables. We anticipate new programs coming online soon. The Company increased our overall marketing efforts using platforms targeted for decision makers, and we are starting to see a response from these efforts. In the meantime, we will be working on current client projects.”

The Company continues to work with groups on long-term projects with long-term revenue potential. Currently, the Company is working with two separate groups in Michigan to provide end-to-end solutions in an effort to form a strategic alliance to support a cannabis business franchise model throughout the state. The Company is working with one group to develop, deploy and manage large commercial-scale operations for the cultivation of recreational wholesale cannabis. This operation will cultivate premiere cannabis cultivars utilizing the best-in-class technologies, software, and workflow. The Company is working with another group to develop and deploy retail franchise and microbusiness locations as well as manage and support franchisees with the model.

Update on Recent Acquisition of Naturaleaf

On April 30, 2021 Colorado’s Marijuana Enforcement Division (MED) and the City of Colorado Springs granted regulatory approvals for the Company’s acquisition and operation of Medihemp, LLC, and its wholly owned subsidiary SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc., all doing business as Naturaleaf, a long-standing vertically integrated cannabis business.

As a result of the regulatory approvals and the closing of the asset purchase, the Company acquired Naturaleaf’s three medically licensed retail stores, and a 10,000 square foot cultivation and extraction facility located in the metropolitan area of Colorado Springs. “We are very happy to have successfully completed this first acquisition. Utilizing the expertise of Karen Thomas and her company, Canna Support Services, ACC was able to deliver organized documentation to all regulatory bodies in a format that not only clearly laid out our public company organizational structure, but also provided the necessary details to attain State and local approval quickly,” said Terry Buffalo, CEO of American Cannabis Company.

Naturaleaf has earned a strong reputation for its quality products and patient experience, having served its loyal and growing patient base since 2009. Since acquiring Naturaleaf many changes have been implemented within the cultivation operation. Ellis Smith, President of American Cannabis Company, Inc., commented: “In just the short amount of time that we have taken ownership of Naturaleaf, our team has implemented multiple new processes and facility changes to improve overall facility cleanliness, quality of work life for employees, and environmental conditions for enhanced flower production. From re-painting walls to switching old equipment for state-of-the art LED lighting and highly efficient HVAC solutions, the upgrading process is just getting started. We have also integrated task management software to improve employee and team workflow at each stage of cultivation and post-harvesting. Soon we will incorporate automated watering throughout the facility coupled with our geoponics grow methodology to further increase biomass and flower yields. Until then we are still harvesting plants from previous ownership, as it takes time to move through the plant cycles. Brand integration on the cultivation side will continue through this year as we maintain rollout of our preferred technologies, standard operating procedures, and methodologies for growing clean, cage-free cannabis.”

In addition to the various modifications taking place at the cultivation facility, many improvements are being made to the three (3) licensed retail locations. Tyler Schloesser, Chief Operating Officer of American Cannabis Company, Inc., commented: “When it comes to the brand integration, much of our focus on the retail side has been on product analysis and customer purchase behavior. This year many medically licensed retailers in the area experienced a dip in average daily sales, and Naturaleaf has also felt this effect. To increase awareness of new brand ownership and promote updated daily specials, pricing and other incentives, the team has targeted well known channels with digital and print advertising diversified throughout the city of Colorado Springs and surrounding areas. Recently, we updated the Naturaleaf logo to fall more aesthetically in line with the ACC brand platform. This logo change, along with other upcoming aesthetic changes to the retail stores, will further serve to tell the story of our brand and our mission, which is to bring quality products and service to our patients. Furthermore, we have made changes on the technology side of the retail experience, including the deployment of a new vertically integrated point-of-sale software this month to streamline transactions and a text-based marketing platform to better communicate with our members. We will continue to assess each retail location along with customer demographics and purchasing patterns to further refine and enhance the customer experience.”

Update on Acquisition Targets

In December of 2020, the Company executed a non-binding letter of intent (LOI) with Andina Gold Corporation/Rocky Mountain High to purchase assets of its Good Meds and BOSM Labs operating division, a fully licensed cultivation and extraction operation in Colorado. The Company decided to not complete this transaction.

The Economics of Agriculture & SoHum Living Soils®

SoHum Living Soils® was created to combat complex cannabis cultivation strategies, both on a home and commercial scale. Originating from Southern Humboldt, California, this potting mix is a complete blend that optimizes a plants genetic potential. Last year, the Company experienced significant growth in product sales, and many steps were taken internally to scale production in order to meet the demand.

This year, sales have leveled off from the surge seen in 2020, and operations. While the audience of SoHum Living Soils® has maintained during the pandemic, certain economic factors have hindered the advancement of overall brand growth and sales. Primarily, soil manufacturers across North America have been impacted negatively by increased costs of material inputs and heightened labor costs.

“The Company is pleased to report that despite these industry hurdles, it has maintained inventory of SoHum Living Soils®. The Operations team has worked closely with its soil manufacturing partners to produce and palletize soil on larger scales to ensure product availability across the country,” said Jon Workman, Vice President of American Cannabis Company. “With the price of individual inputs climbing, increased pressure is being put on soil manufacturers on a national scale. Notwithstanding such challenges, our Operations and Sales teams have worked closely reduce the impact on our retailers, distributors, and customer base. We strive to preserve and maintain product quality as well as brand integrity, and it is important to us to maintain product availability.”

Those looking to purchase SoHum Living Soils® can do so by contacting an official distributor or visiting the official website. The SoHum Living Soils® potting mix is also available for purchase on the Walmart, The Home Depot and Amazon online store platforms.

New & Upcoming

The Company has worked diligently to remain on the cutting edge of the fast-paced cannabis industry. In this pursuit, many additions have been made to the company portfolio in effort to advance the Company’s long-term goals and vision to expand brand assets and strengthen industry alliances.

Research and development functions have increased tremendously with the Company now having a 10,000 square foot cultivation facility to perform testing functions and grow trials. Trials on new soil blends and solutions are currently underway to expand the SoHum Living Soils® product line. Furthermore, the Company has been able to officially roll out a proprietary air circulation technology for cannabis cultivation. This solution, called Bottoms uP™ The Science of Air Flow, is essentially a means to move “conditioned” air that is coming from HVAC unit vertically from beneath the plant leaves. This vertical air flow forces the water leaves (which are interlocked late in the flower cycle) apart so that the trapped air beneath the canopy can rise.

This trapped air is the water vapor that is transpired through the plant’s stomata which is on the underside of the water leaves. This solution not only makes air flow more efficient, it also increases transpiration rates and allows for more effective plant growth.

Additionally, the Company recently finalized an exclusive manufacturing and distribution agreement with Her Highness NYC within the state of Colorado. Her Highness NYC features premiere designer cannabis products and accessories designed and engineered thoughtfully for women by women who are passionate and determined to expand the ever-growing market of female consumers. In a recent mid-year report, Akerna (NASDAQ: KERN) highlighted trends showing that since 2019, females have steadily increased their percentage of cannabis purchases, and are while men still purchase a majority of cannabis and related products, women are increasing purchases at a steady pace, and challenging the industry to up its game in order to compete for their business. (https://www.greenmarketreport.com/15-million-women-have-bought-cannabis-in-2021/)

“Securing this opportunity with Her Highness marks a significant accomplishment for American Cannabis Company,” said Terry Buffalo, Chief Executive Officer of American Cannabis Company. Buffalo continued, “Our team is very excited for the potential market demand and is enthusiastic to launch this brand locally starting this September. We will initially offer these products on the medical side via our Naturaleaf retail channels, and then look to bring Her Highness NYC to the rest of the Colorado market. For many years there has been a gap in this industry, as most products have been marketed to male-focused demographics. With female consumers making up an increasingly large portion of the market, brands like Her Highness have established themselves to provide premiere products that are made to deliver experiences that elevate and celebrate women.”

The Her Highness collection of products include bespoke long crutch pre-roll cones packed in gold boxes with refillable gold lighters, the brands famous Pleasure Oil, gluten free 2.5mg micro-dose THC mints, luxuriously engineered gold Giggle and High Priestess vape pens, deluxe ashtrays constructed with marble and brass, gold tone luxe herb grinders and elegant smoking accessories.

About American Cannabis Company, Inc.

American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. We are continuing to grow the company by promoting our operational management services and license the American Cannabis Company brand as well as continuing to analyze acquisition opportunities worldwide. The Company currently owns and operates Naturaleaf in Colorado Springs, Colorado. This medically licensed entity consists of three (3) retail dispensaries, one (1) commercial cultivation facility, and one (1) non-volatile extraction operation. American Cannabis Company has also developed and currently owns a portfolio of branded products including: SoHum Living Soils® – Winner of the High Times S.T.A.S.H. Award for “Best Potting Mix,” The Cultivation Cube™ and the High-Density Cultivation System™. American Cannabis Company also designs and provides other industry-specific custom product solutions.

 

For more information about American Cannabis Company, please visit:

www.theacclife.com
www.americancannabisconsulting.com
www.americancannabiscompanyinc.com
www.sohumsoils.com
www.americanhempservices.com
www.thenaturaleaf.com

 

Video Links:

https://americancannabisconsulting.com/resources/video/ (ACC Site)
https://www.youtube.com/watch?v=aENC4aeNZis (High Density Cultivation System)
https://www.youtube.com/watch?v=e9rNxFph_tQ&t (Cultivation Cube)
https://www.youtube.com/watch?v=XoIcopO2yE8&t (SoHum Living Soils®)

 

ACC Contact:

[email protected]

Phone: 303-974-4770

 

About Canna Support Services

At Canna Support Services, your business success is our priority. Our mission is to provide the highest level of integrity, confidentiality, professionalism and customer service to you while never compromising our reputation or yours. We provide a suite of support services to the cannabis industry, from license renewals to project management, implementing ultra-efficient work processes through personalized contracted services. Canna Support Services is ready to tackle any challenge and put you on the path to success, and we aim to partner with you to provide the foundation to achieve your business goals.

 

For more information about Canna Support Services, please visit:

www.cannasupportservices.com

Canna Support Services Contact:

[email protected]

720-237-2500

 

Forward-Looking Statements

This news release contains “forward-looking statements,” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”. These or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

Cannabis Remains an Illegal Schedule 1 Drug Under Federal Law

Thirty-five states, including Colorado, the District of Columbia and four U.S. Territories currently have laws broadly legalizing cannabis in some form for either medicinal and/or recreational use governed by state specific laws and regulations. Although legalized in some states, cannabis is a “Schedule 1” drug under the Controlled Substances Act (21 U.S.C. § 811) (“CSA”) and is illegal under federal law. Cannabis and its derivatives are viewed as being highly addictive and having no medical value. The United States Drug Enforcement Agency enforces the Controlled Substances Act, and persons violating it are subject to federal criminal prosecution.

As a result of the November 2020 federal elections, and the election of Joseph R. Biden as president, it is expected that the federal government will move to amend parts of the CSA and de-schedule cannabis as a Schedule 1 drug.

In late January, 2021, Senate Majority Leader Chuck Schumer said lawmakers are in the process of merging various cannabis bills, including his own legalization legislation. He is working to enact reform in this Congressional session. This would include the Marijuana Freedom and Opportunity Act, that would federally de-schedule cannabis, reinvest tax revenue into communities most affected by the drug war, and fund efforts to expunge prior cannabis records. It is likely that the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act would be incorporated.

Other federal legislation under review for possible submission includes the SAFE Banking Act (or Secure and Fair Enforcement Act), a bill that would allow cannabis companies to access the federally-insured banking system and capital markets without the risk of federal enforcement action, and the Strengthening the Tenth Amendment Through Entrusting States Act (or STATES Act), a bill that seeks protections for businesses and individuals in states that have legalized and comply with state laws).

Notably with respect to our business, on November 1, 2019, Colorado Bill HB-19-1090, was passed and made effective. This law allows publicly traded corporations to apply for and qualify for the ownership of Colorado cannabis licenses. Other states that have legalized cannabis for recreational and/or medicinal use restrict public companies from owning interests in state cannabis licenses altogether, or have enacted regulations which make it difficult for corporations to comply with application requirements, including all shareholders submitting to and passing background checks.

On September 18, 2020, Colorado’s Marijuana Enforcement Division (MED), approved the Company’s application for suitability, establishing the Company as one of the few publicly traded companies authorized to acquire and operate various cannabis licenses throughout Colorado, in both the recreational and medical markets.

American Cannabis Company, Inc. Announces Exclusive Contract to Manufacture and
Distribute Her Highness Branded Products in Colorado

DENVER, CO / NEWMEDIAWIRE / May 13, 2021 American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC” or “Company”) is pleased to announce that it has finalized an exclusive manufacturing and distribution agreement with Her Highness NYC (“Her Highness”) within the state of Colorado. Her Highness features premiere designer cannabis products and accessories designed and engineered thoughtfully for women by women who are passionate and determined to expand the ever-growing market of female consumers.

“Securing this opportunity with Her Highness marks a significant accomplishment for American Cannabis Company,” said Terry Buffalo, Chief Executive Officer of American Cannabis Company. Buffalo continued, “Our team is very excited and enthusiastic to launch Her Highness in Colorado. For many years there has been a gap in this industry, as most products have been marketed to male-focused demographics. With female consumers making up a large portion of the market, brands like Her Highness have established themselves to provide premiere products that are made to deliver experiences that elevate and celebrate women.”

The Her Highness collection of products include bespoke long crutch pre-roll cones packed in gold boxes with refillable gold lighters, the brands famous “highly orgasmic” Pleasure Oil, gluten free 2.5mg micro-dose THC mints, luxuriously engineered gold Giggle and High Priestess vape pens, deluxe ashtrays constructed with marble and brass, gold tone luxe herb grinders and elegant smoking accessories.

Allison Krongard, co-founder of Her Highness also commented: “As a New York-based brand, we could not be more excited and honored to bring our cannabis collection to Colorado, ground-zero for regulated cannabis. Through its retail channels as well as via the wholesale market, American Cannabis Company will be providing consumers with our catalog of female-forward cannabis couture.” Laura Eisman, co-founder of Her Highness also commented: “We’re thrilled to have ACC as a licensing partner as we look to expand into additional legal markets throughout the US and internationally. With a mission to introduce and educate women on the benefits of cannabis, we aim to offer products tailored to enhance the experience of life. The future of cannabis is feminine, and we are at the forefront.”

About American Cannabis Company, Inc.

American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. We are continuing to grow the company by promoting our operational management services and license the American Cannabis Company brand as well as continuing to analyze acquisition opportunities worldwide. American Cannabis Company also developed and owns a portfolio of branded products including: SoHum Living Soils® – Winner of the High Times S.T.A.S.H. Award for “Best Potting Mix,” The Cultivation Cube™ and the High-Density Cultivation System™. American Cannabis Company also designs and provides other industry-specific custom product solutions.

For more information about American Cannabis Company, please visit:

www.theacclife.com
www.americancannabisconsulting.com
www.americancannabiscompanyinc.com
www.sohumsoils.com
www.americanhempservices.com

Video Links:

https://americancannabisconsulting.com/resources/video/ (ACC Site)
https://www.youtube.com/watch?v=aENC4aeNZis (High Density Cultivation System)
https://www.youtube.com/watch?v=e9rNxFph_tQ&t (Cultivation Cube)
https://www.youtube.com/watch?v=XoIcopO2yE8&t (SoHum Living Soils®)

About Her Highness

Backed by Merida Capital, Her Highness is a female-first lifestyle cannabis brand based in New York, designed for the modern cannabis consumer. With an elevated brand aesthetic, a sophisticated collection of cannabis and CBD products and stylish consumption accessories, Her Highness is created for the feminine lifestyle. Her Highness’ accessories and CBD line retails online with their THC line available in California, Nevada, Massachusetts and soon, Colorado,  Pennsylvania and Ohio. Curated with female-friendly effects like clear head, sans-munchies, anxiety-free and high-functioning, Her Highness products are developed to benefit women, addressing specific needs in their daily lives. Through a partnership with the Last Prisoner Project, Her Highness raises funds for women with non-violent cannabis convictions working towards or reentering after release.

For more information about Her Highness, please visit:
www.herhighness.com
@herhighnessnyc on all social platforms

ACC Contact:
[email protected]
303-974-4770

Her Highness Media Contact:
[email protected]

Forward-Looking Statements

This news release contains “forward-looking statements,” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”. These or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

Cannabis Remains an Illegal Schedule 1 Drug Under Federal Law

Thirty-five states, including Colorado, the District of Columbia and four U.S. Territories currently have laws broadly legalizing cannabis in some form for either medicinal and/or recreational use governed by state specific laws and regulations. Although legalized in some states, cannabis is a “Schedule 1” drug under the Controlled Substances Act (21 U.S.C. § 811) (“CSA”) and is illegal under federal law. Cannabis and its derivatives are viewed as being highly addictive and having no medical value. The United States Drug Enforcement Agency enforces the Controlled Substances Act, and persons violating it are subject to federal criminal prosecution.

As a result of the November, 2020 federal elections, and the election of Joseph R. Biden as president, it is expected that the federal government will move to amend parts of the CSA and de-schedule cannabis as a Schedule 1 drug.

In late January, 2021, Senate Majority Leader Chuck Schumer said lawmakers are in the process of merging various cannabis bills, including his own legalization legislation. He is working to enact reform in this Congressional session. This would include the Marijuana Freedom and Opportunity Act, that would federally de-schedule cannabis, reinvest tax revenue into communities most affected by the drug war, and fund efforts to expunge prior cannabis records. It is likely that the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act would be incorporated.

Other federal legislation under review for possible submission includes the SAFE Banking Act (or Secure and Fair Enforcement Act), a bill that would allow cannabis companies to access the federally-insured banking system and capital markets without the risk of federal enforcement action, and the Strengthening the Tenth Amendment Through Entrusting States Act (or STATES Act), a bill that seeks protections for businesses and individuals in states that have legalized and comply with state laws).

Notably with respect to our business, on November 1, 2019, Colorado Bill HB-19-1090, was passed and made effective. This law allows publicly traded corporations to apply for and qualify for the ownership of Colorado cannabis licenses. Other states that have legalized cannabis for recreational and/or medicinal use restrict public companies from owning interests in state cannabis licenses altogether, or have enacted regulations which make it difficult for corporations to comply with application requirements, including all shareholders submitting to and passing background checks.

On September 18, 2020, Colorado’s Marijuana Enforcement Division (MED), approved the Company’s application for suitability, establishing the Company as one of the few publicly traded companies authorized to acquire and operate various cannabis licenses throughout Colorado, in both the recreational and medical markets.

 

American Cannabis Company, Inc. Receives Approval from Colorado’s Marijuana Enforcement Division (MED) and the City of Colorado Springs to Acquire, Own, and Operate Naturaleaf™ in Southern Colorado

DENVER, CO / NEWMEDIAWIRE / May 4, 2021 – American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC” or “Company”) is pleased to announce that on April 30, 2021,  Colorado’s Marijuana Enforcement Division (MED) and the City of Colorado Springs granted regulatory approvals for the Company’s acquisition and operation of Medihemp, LLC, and its wholly owned subsidiary SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc., all doing business as Naturaleaf™, a long-standing vertically integrated cannabis business.

As a result of the regulatory approvals and the closing of the asset purchase, the Company acquired Naturaleaf’s three medically licensed retail stores, and a 10,000 square foot cultivation and extraction facility located in the metropolitan area of Colorado Springs. Naturaleaf™ has earned a strong reputation for its quality products and customer experience, having served its loyal and growing patient base since 2009.

“We are incredibly happy to have completed this acquisition, and this is only the beginning,” said Terry Buffalo, Chief Executive Officer of American Cannabis Company. Buffalo continued, “With the approval from the regulatory bodies now behind us, this is where the real work starts. Brand integration is key for success, and our team is working diligently to dial in processes and procedures, as well as implementing ACC’s company culture and core values, while also maintaining Naturaleaf™ brand integrity. We look to expand production capacities by revamping the cultivation operation, adding technology and equipment, including our proprietary cultivation methodologies and ‘just add water’ all-natural potting mix, SoHum Living Soils®, to effectively grow a consistent, high-value flower product. In addition to the modifications we plan to make in the back of the house, we also aim to elevate the retail experience by adding best-in-market products, new retail equipment and technologies to maximize customer/patient experience, as well as maintain consistent inventories. With this acquisition we anticipate over $2mm+ in gross revenue, and we look to increase upon that. For more details, please read the Company’s most recent 8-K filings.”

Scott Saunders, owner of Naturaleaf™, commented: “We are happy to have been acquired by American Cannabis Company. Since 2009 Naturaleaf has been pioneering the local medical market. The staff is excited to transition under the ownership of a public company, and I am excited for the people of Colorado Springs to see what American Cannabis Company is going to bring to the local community.”

Overall Transaction Background

On December 10, 2020, American Cannabis Company announced that it had executed a non-binding letter of intent to acquire all three (3) Naturaleaf™ medical marijuana centers along with its ten thousand (10,000) square foot commercial cultivation facility that also includes non-volatile extraction facilities.

On March 11, 2021, American Cannabis Company announced that it had executed the official Asset Purchase Agreement (APA) and on April 20, 2021 the Company received a contingent approval letter from Colorado’s Marijuana Enforcement Division (MED), outlining the change of ownership.

After now having obtained final regulatory approval transferring the Naturaleaf™ licenses to the Company, and finalizing the closing of the asset purchase transaction as of April 30, 2021, the Company plans to acquire additional local and national cannabis assets and brands, with the goal of creating a portfolio of cannabis assets elevating the consumer experience through a commitment to wellness, quality products, and cleaner green practices.

For a complete disclosure of the asset purchase agreement, see the Company’s Form 8-K filed with the Securities and Exchange Commission:

https://www.sec.gov/Archives/edgar/data/945617/000172186821000142/f2sammj8k031121.htm

For a complete disclosure of the acquisition for Naturaleaf™ and the received regulatory approval, see the Company’s Form 8-K filed with the Securities and Exchange Commission:

https://www.sec.gov/Archives/edgar/data/945617/000172186821000254/f2sammj8k043021.htm

About American Cannabis Company, Inc.

 American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. We are continuing to grow the company by promoting our operational management services and license the American Cannabis Company brand as well as continuing to analyze acquisition opportunities worldwide. American Cannabis Company also developed and owns a portfolio of branded products including: SoHum Living Soils® – Winner of the High Times S.T.A.S.H. Award for “Best Potting Mix,” The Cultivation Cube™ and the High-Density Cultivation System™. American Cannabis Company also designs and provides other industry-specific custom product solutions.

For more information about American Cannabis Company, please visit:

www.theacclife.com

www.americancannabisconsulting.com
www.americancannabiscompanyinc.com
www.sohumsoils.com

www.americanhempservices.com

Video Links:

https://americancannabisconsulting.com/resources/video/ (ACC Site)

https://www.youtube.com/watch?v=aENC4aeNZis (High Density Cultivation System)

https://www.youtube.com/watch?v=e9rNxFph_tQ&t (Cultivation Cube)

https://www.youtube.com/watch?v=XoIcopO2yE8&t (SoHum Living Soils®)

About Naturaleaf™

Naturaleaf™, a well-known brand frequently sought out by locals in the Colorado Springs area, has been providing medical patients with cannabis and cannabis-derived products for over ten (10) years. It’s staff and patient specialists maintain a very active presence in the local community, strive to find patients the right medicine for present or given conditions, and promote cannabis education to its patrons in a one-on-one retail concierge experience.

For more information on Naturaleaf™, please visit:

www.thenaturaleaf.com

 

Contact:
[email protected]

303-974-4770

 

Forward-Looking Statements

This news release contains “forward-looking statements,” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”. These or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

 

Cannabis Remains an Illegal Schedule 1 Drug Under Federal Law

 

Thirty-five states, including Colorado, the District of Columbia and four U.S. Territories currently have laws broadly legalizing cannabis in some form for either medicinal and/or recreational use governed by state specific laws and regulations. Although legalized in some states, cannabis is a “Schedule 1” drug under the Controlled Substances Act (21 U.S.C. § 811) (“CSA”) and is illegal under federal law. Cannabis and its derivatives are viewed as being highly addictive and having no medical value. The United States Drug Enforcement Agency enforces the Controlled Substances Act, and persons violating it are subject to federal criminal prosecution.

 

As a result of the November, 2020 federal elections, and the election of Joseph R. Biden as president, it is expected that the federal government will move to amend parts of the CSA and de-schedule cannabis as a Schedule 1 drug.

 

In late January, 2021, Senate Majority Leader Chuck Schumer said lawmakers are in the process of merging various cannabis bills, including his own legalization legislation. He is working to enact reform in this Congressional session. This would include the Marijuana Freedom and Opportunity Act, that would federally de-schedule cannabis, reinvest tax revenue into communities most affected by the drug war, and fund efforts to expunge prior cannabis records. It is likely that the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act would be incorporated.

 

Other federal legislation under review for possible submission includes the SAFE Banking Act (or Secure and Fair Enforcement Act), a bill that would allow cannabis companies to access the federally-insured banking system and capital markets without the risk of federal enforcement action, and the Strengthening the Tenth Amendment Through Entrusting States Act (or STATES Act), a bill that seeks protections for businesses and individuals in states that have legalized and comply with state laws).

 

Notably with respect to our business, on November 1, 2019, Colorado Bill HB-19-1090, was passed and made effective. This law allows publicly traded corporations to apply for and qualify for the ownership of Colorado cannabis licenses. Other states that have legalized cannabis for recreational and/or medicinal use restrict public companies from owning interests in state cannabis licenses altogether, or have enacted regulations which make it difficult for corporations to comply with application requirements, including all shareholders submitting to and passing background checks.

 

On September 18, 2020, Colorado’s Marijuana Enforcement Division (MED), approved the Company’s application for suitability, establishing the Company as one of the few publicly traded companies authorized to acquire and operate various cannabis licenses throughout Colorado, in both the recreational and medical markets.

American Cannabis Company, Inc. Announces Formation of Advisory Board

DENVER, CO / NEWMEDIAWIRE / March 18, 2021 – American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC” or “Company”) is pleased to announce its newly formed Advisory Board consisting of cannabis and non-cannabis sector professionals, who will provide guidance relating to the Company’s strategic plans and initiatives, and highlight potential key areas of opportunity within the industry for ACC and its portfolio of brand assets to capitalize upon.

Terry Buffalo, CEO of American Cannabis Company, commented: “We are thrilled to be officially launching the ACC Advisory Board. The Executive Team has taken several months to carefully compile a list of top professionals who each bring unique strengths and backgrounds to the table. We are proud to say that we have selected these seven (7) individuals as our inaugural members.”

Advisory Board Members include*:

Christine Comatos
Elvin Moon
Karen Thomas
Peggy Moore
Breck Speed
Greg Shoenfeld
Carolyn Burek

*for Member-specific bios, please visit:
https://americancannabisconsulting.com/about/advisory-board/

Buffalo continued, “As a public company that is solidifying itself as a long-standing player in the cannabis industry, the team and I wanted to develop an advisory group of individuals who we felt could provide their respective insights in parallel with the deployment of our strategies for brand asset growth and expansion. We look forward to working closely with this group and will continue to evaluate additional member candidates as our growth trajectory progresses.”

About American Cannabis Company, Inc.

American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. We are continuing to grow the company by promoting our operational management services and license the American Cannabis Company brand as well as continuing to analyze acquisition opportunities worldwide. American Cannabis Company also developed and owns a portfolio of branded products including: SoHum Living Soils® – Winner of the High Times S.T.A.S.H. Award for “Best Potting Mix,” The Cultivation Cube™ and the High-Density Cultivation System™. American Cannabis Company also designs and provides other industry-specific custom product solutions.

For more information about American Cannabis Company, please visit:
www.theacclife.com
www.americancannabisconsulting.com
www.americancannabiscompanyinc.com
www.sohumsoils.com
www.americanhempservices.com

Video Links:
https://americancannabisconsulting.com/resources/video/ (ACC Site)
https://www.youtube.com/watch?v=aENC4aeNZis (High Density Cultivation System)
https://www.youtube.com/watch?v=e9rNxFph_tQ&t (Cultivation Cube)
https://www.youtube.com/watch?v=XoIcopO2yE8&t (SoHum Living Soils®)

Contact:
[email protected]
303-974-4770


Forward-Looking Statements

This news release contains “forward-looking statements,” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”. These or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

Cannabis Remains an Illegal Schedule 1 Drug Under Federal Law

Thirty-five states, including Colorado, the District of Columbia and four U.S. Territories currently have laws broadly legalizing cannabis in some form for either medicinal and/or recreational use governed by state specific laws and regulations. Although legalized in some states, cannabis is a “Schedule 1” drug under the Controlled Substances Act (21 U.S.C. § 811) (“CSA”) and is illegal under federal law. Cannabis and its derivatives are viewed as being highly addictive and having no medical value. The United States Drug Enforcement Agency enforces the Controlled Substances Act, and persons violating it are subject to federal criminal prosecution.

As a result of the November, 2020 federal elections, and the election of Joseph R. Biden as president, it is expected that the federal government will move to amend parts of the CSA and de-schedule cannabis as a Schedule 1 drug.

In late January, 2021, Senate Majority Leader Chuck Schumer said lawmakers are in the process of merging various cannabis bills, including his own legalization legislation. He is working to enact reform in this Congressional session. This would include the Marijuana Freedom and Opportunity Act, that would federally de-schedule cannabis, reinvest tax revenue into communities most affected by the drug war, and fund efforts to expunge prior cannabis records. It is likely that the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act would be incorporated.

Other federal legislation under review for possible submission includes the SAFE Banking Act (or Secure and Fair Enforcement Act), a bill that would allow cannabis companies to access the federally-insured banking system and capital markets without the risk of federal enforcement action, and the Strengthening the Tenth Amendment Through Entrusting States Act (or STATES Act), a bill that seeks protections for businesses and individuals in states that have legalized and comply with state laws).

Notably with respect to our business, on November 1, 2019, Colorado Bill HB-19-1090, was passed and made effective. This law allows publicly traded corporations to apply for and qualify for the ownership of Colorado cannabis licenses. Other states that have legalized cannabis for recreational and/or medicinal use restrict public companies from owning interests in state cannabis licenses altogether, or have enacted regulations which make it difficult for corporations to comply with application requirements, including all shareholders submitting to and passing background checks.

On September 18, 2020, Colorado’s Marijuana Enforcement Division (MED), approved the Company’s application for suitability, establishing the Company as one of the few publicly traded companies authorized to acquire and operate various cannabis licenses throughout Colorado, in both the recreational and medical markets.

American Cannabis Company, Inc. Executes Definitive Agreement to Acquire Naturaleaf™ in Southern Colorado

DENVER, CO / NEWMEDIAWIRE / March 16, 2021 – American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC” or “Company”) is pleased to announce that on March 11, 2021, it executed a material definite agreement to acquire the assets and operations of Medihemp, LLC, and its wholly owned subsidiary SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc.,  all doing business as Naturaleaf™, located in the metropolitan area of Colorado Springs, Colorado. A long-standing and reputable medical cannabis retailer in a thriving market, Naturaleaf™ operates three licensed medical marijuana centers, including a 10,000 square foot cultivation facility containing non-volatile extraction facilities, and has provided patients with quality cannabis, cannabis-derived products and related accessories for over ten (10) years.

“For over a decade, Naturaleaf™ has built a brand name that truly speaks for itself. Providing medical quality cannabis and products to its loyal customer base of registered patients through a one-on-one retail concierge experience, this acquisition is something that our team is excited for as we look to improve the overall business performance and increase revenues while maintaining brand integrity,” said Terry Buffalo, CEO of American Cannabis Company.

Buffalo continued, “Through the due diligence process our team identified key performance indicators that we will use as a baseline to improve revenue, operational costs, and identify market trends as a means to fulfill the ever-growing demand. We expect this acquisition to bring in over $2.2mm in gross revenue, and we look to increase upon that. For more details, please read the Company’s most recent 8-K filing. All of the documents required to be filed to complete transfer of the licenses have been filed with the appropriate regulatory agencies, and we anticipate closing the transaction after final regulatory approval, which we expect in the second quarter.”

Scott Saunders, owner of Naturaleaf™, commented: “We are very happy to have Naturaleaf™ join the American Cannabis Company portfolio of brand assets. The staff is excited to transition under the ownership of a public company as this industry continues to emerge and expand, and I am excited for the people of Colorado Springs and Southern Colorado to see what American Cannabis Company can do to a brand that the team and I have spent years building.”

Transaction Background

On December 10, 2020, American Cannabis Company announced that it had executed a non-binding letter of intent to acquire all three (3) Naturaleaf™ medical marijuana centers along with its ten thousand (10,000) square foot commercial cultivation facility that also includes non-volatile extraction facilities.

After obtaining final regulatory approval transferring the Naturaleaf™ licenses to the Company, and finalizing the closing of the asset purchase transaction, the Company plans to acquire additional local and national cannabis assets and brands, with the goal of creating a portfolio of cannabis assets elevating the consumer experience through a commitment to wellness, quality products, and cleaner green practices.

For a complete disclosure of the asset purchase agreement, see the Company’s Form 8-K filed with the Securities and Exchange Commission:

https://www.sec.gov/Archives/edgar/data/945617/000172186821000142/f2sammj8k031121.htm

About American Cannabis Company, Inc.

American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. We are continuing to grow the company by promoting our operational management services and license the American Cannabis Company brand as well as continuing to analyze acquisition opportunities worldwide. American Cannabis Company also developed and owns a portfolio of branded products including: SoHum Living Soils® – Winner of the High Times S.T.A.S.H. Award for “Best Potting Mix,” The Cultivation Cube™ and the High-Density Cultivation System™. American Cannabis Company also designs and provides other industry-specific custom product solutions.

 

For more information about American Cannabis Company, please visit:

www.theacclife.com
www.americancannabisconsulting.com
www.americancannabiscompanyinc.com
www.sohumsoils.com
www.americanhempservices.com

 

Video Links:

https://americancannabisconsulting.com/resources/video/ (ACC Site)
https://www.youtube.com/watch?v=aENC4aeNZis (High Density Cultivation System)
https://www.youtube.com/watch?v=e9rNxFph_tQ&t (Cultivation Cube)
https://www.youtube.com/watch?v=XoIcopO2yE8&t (SoHum Living Soils®)

For more information on Naturaleaf, please visit:

www.thenaturaleaf.com

Contact:
[email protected]

303-974-4770

 

Forward-Looking Statements

This news release contains “forward-looking statements,” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”. These or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

 

Cannabis Remains an Illegal Schedule 1 Drug Under Federal Law

Thirty-five states, including Colorado, the District of Columbia and four U.S. Territories currently have laws broadly legalizing cannabis in some form for either medicinal and/or recreational use governed by state specific laws and regulations. Although legalized in some states, cannabis is a “Schedule 1” drug under the Controlled Substances Act (21 U.S.C. § 811) (“CSA”) and is illegal under federal law. Cannabis and its derivatives are viewed as being highly addictive and having no medical value. The United States Drug Enforcement Agency enforces the Controlled Substances Act, and persons violating it are subject to federal criminal prosecution.

As a result of the November, 2020 federal elections, and the election of Joseph R. Biden as president, it is expected that the federal government will move to amend parts of the CSA and de-schedule cannabis as a Schedule 1 drug.

In late January, 2021, Senate Majority Leader Chuck Schumer said lawmakers are in the process of merging various cannabis bills, including his own legalization legislation. He is working to enact reform in this Congressional session. This would include the Marijuana Freedom and Opportunity Act, that would federally de-schedule cannabis, reinvest tax revenue into communities most affected by the drug war, and fund efforts to expunge prior cannabis records. It is likely that the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act would be incorporated.

Other federal legislation under review for possible submission includes the SAFE Banking Act (or Secure and Fair Enforcement Act), a bill that would allow cannabis companies to access the federally-insured banking system and capital markets without the risk of federal enforcement action, and the Strengthening the Tenth Amendment Through Entrusting States Act (or STATES Act), a bill that seeks protections for businesses and individuals in states that have legalized and comply with state laws).

Notably with respect to our business, on November 1, 2019, Colorado Bill HB-19-1090, was passed and made effective. This law allows publicly traded corporations to apply for and qualify for the ownership of Colorado cannabis licenses. Other states that have legalized cannabis for recreational and/or medicinal use restrict public companies from owning interests in state cannabis licenses altogether, or have enacted regulations which make it difficult for corporations to comply with application requirements, including all shareholders submitting to and passing background checks.

On September 18, 2020, Colorado’s Marijuana Enforcement Division (MED), approved the Company’s application for suitability, establishing the Company as one of the few publicly traded companies authorized to acquire and operate various cannabis licenses throughout Colorado, in both the recreational and medical markets.

 

 

American Cannabis Company, Inc. Discusses Its 2021 Acquisition Strategy with The Stock Day Podcast

Phoenix, Arizona–(Newsfile Corp. – January 28, 2021) – The Stock Day Podcast welcomed American Cannabis Company, Inc. (OTCQB: AMMJ) (“the Company”), a company that offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. CEO of the Company, Terry Buffalo, joined Stock Day host Everett Jolly.

Jolly commented on the Company’s impressive growth over the last year, and asked about their background and current projects. “American Cannabis Company has been around since 2013,” shared Buffalo. “The company has built out over 2 million square feet of growth space, and along the way we have been looking to add additional products and services, which we have with SoHum Living Soils®,” he continued. “We’re currently looking to make these acquisitions and we’re happy to be able to diversify our income, and hopefully level our income, by adding these acquisitions to our portfolio.”

Jolly then asked about the Company’s recent announcement detailing a non-binding Letter of Intent (LOI) to purchase assets of Good Meds and BOSM Labs, a cannabis cultivation and extraction facility operating in a 60,000 sq. ft. building. “We have started the due diligence and the audit process is underway, and we’re looking to close this acquisition hopefully in the second quarter of this year,” said Buffalo. “It provides us the opportunity to expand up to 60,000 sq. ft. to help meet the growing medical and adult demand in the Colorado market.”

The conversation then turned to BOSM Labs, which produces live resin, live batter, budder, and shatter. “One of the big advantages of BOSM is that it is a hydrocarbon extraction lab. So, that will provide us the ability to add new products, SKUs, and meet the ever-growing demand here in the Colorado market.”

“What do you think will be some of the catalysts you will try to get done in the next two to three quarters?” asked Jolly. “The biggest thing is to get these two acquisitions that we have on the schedule for 2021, get them integrated into the company, and then start looking for 2022 opportunities,” said Buffalo.

Buffalo then elaborated on the Company’s consulting services division. “We’ve seen a big increase in calls and emails into the company. We have new clients now in all five states, and we are currently looking to add a few more in each one of those five states,” said Buffalo. “We’re looking for additional states to potentially come onboard before the end of the year, which will hopefully increase our consulting business for 2021.”

To close the interview, Buffalo shared that the Company will continue to be strategic in their acquisitions with a strong focus on building shareholder value. “We’re not just looking at top-line numbers, we’re looking to see how we can have profit,” said Buffalo. “That is our goal and I appreciate our shareholders being patient,” he added. “We’re working every day to bring value and provide a much cleaner type of product for the consumer than what is out there right now. Cleaner and greener is always the standard.”

To hear Terry Buffalo’s entire interview, follow the link to the podcast here: https://audioboom.com/posts/7784397-american-cannabis-company-inc-discusses-its-2021-acquisition-strategy-with-the-stock-day-podcast

Investors Hangout is a proud sponsor of “Stock Day,” and Stock Day Media encourages listeners to visit the company’s message board at https://investorshangout.com/

About American Cannabis Company, Inc.

American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. We are continuing to grow the Company by promoting our operational management services, and license the American Cannabis Company brand, as well as continuing to analyze acquisition opportunities worldwide. American Cannabis Company also developed and owns a portfolio of branded products including: SoHum Living Soils® – Winner of the High Times S.T.A.S.H Award for “Best Potting Mix”, The Cultivation Cube™ and the High-Density Cultivation System™. We also design and provide other industry specific custom product solutions.

For more information about American Cannabis Company, please visit:
www.theacclife.com
www.americancannabisconsulting.com
www.americancannabiscompanyinc.com
www.sohumsoils.com
www.americanhempservices.com

For more information on Good Meds, please visit:
https://www.goodmeds.com/

For more information on BOSM Labs, please visit:
https://www.goodmeds.com/bosm-labs/

Video Links:
https://americancannabisconsulting.com/resources/video/ (ACC Site)
https://www.youtube.com/watch?v=aENC4aeNZis (High Density Cultivation System)
https://www.youtube.com/watch?v=e9rNxFph_tQ&t (Cultivation Cube)
https://www.youtube.com/watch?v=XoIcopO2yE8&t (SoHum Living Soils®)

Forward Looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

Cannabis Remains an Illegal Schedule 1 Drug Under Federal Law

Cannabis and its derivatives are considered illegal “Schedule 1” drugs under the Controlled Substances Act (21 U.S.C. § 811). As such, Cannabis and its derivatives are viewed as being highly addictive and having no medical value. The United States Drug Enforcement Agency enforces the Controlled Substances Act, and persons violating it are subject to federal criminal prosecution. The criminal penalty structure in the Controlled Substances Act is determined based on the specific predicate violations, including but not limited to: simple possession, drug trafficking, attempt and conspiracy, distribution to minors, trafficking in drug paraphernalia, money laundering, racketeering, environmental damage from illegal manufacturing, continuing criminal enterprise, and smuggling. A first conviction under the Controlled Substances Act can generally result in possible fines from $250,000 to $50 million dollars, and incarceration for periods generally from five and up to forty years. For a second conviction, fines increase generally from $500,000 to $75 million dollars, and incarceration for periods generally from ten years to twenty years to life.

Contact:

[email protected]
303-974-4770

About The “Stock Day” Podcast

Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America. Stock Day recently launched its Video Interview Studio located in Phoenix, Arizona.

SOURCE:

Stock Day Media
(602) 821-1102

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/73058